Related Experiment Video
Updated: Apr 20, 2026
04:24
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
12.9K
Exercise therapy for heart failure patients in Canada
James A Stone1, Trina Hauer2, Mark Haykowsky3
1Cardiac Wellness Institute of Calgary, Calgary, Alberta, Canada; Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada.
Heart Failure Clinics
|November 30, 2014
Summary
Exercise therapy, including aerobic and resistance training, can significantly improve the quality of life and physical capacity for patients with heart failure (HF). Adherence to exercise programs may also reduce rehospitalization rates in this population.
Area of Science:
- Cardiology
- Exercise Physiology
Background:
- Heart failure (HF) is a complex condition associated with significant deconditioning.
- Pharmacologic therapies have improved HF outcomes, but non-pharmacologic interventions are gaining importance.
Purpose of the Study:
- To highlight the benefits of exercise therapy in patients with heart failure.
- To explore the impact of exercise on functional capacity and rehospitalization.
Main Methods:
- Review of current understanding of exercise therapy in heart failure.
- Analysis of the effects of aerobic and resistance training on HF patients.
Main Results:
- Exercise therapy can enhance quality of life, muscular strength, and aerobic capacity.
- Adherence to exercise may improve self-monitoring and independent living skills.
- Potential for increased longevity and reduced rehospitalization rates.
Conclusions:
- Exercise therapy is a valuable adjunct to pharmacologic treatment for heart failure.
- Regular exercise can mitigate deconditioning and improve patient outcomes.
- Promoting adherence to exercise programs is crucial for managing heart failure effectively.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
614
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
614
01:30Heart Failure V: Medical Management
594
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
594
01:30Heart Failure VII: Nursing Interventions
771
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
771
01:29Cardiomyopathy V: Interprofessional Care
732
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
732
01:22Heart Failure Drugs: β-Blockers
1.2K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.2K
01:30Heart Failure IV: Classification and Diagnostic Evaluation
651
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
651